Treatment strategies for hot flushes

Area of Science:

• Menopause Management
• Women's Health
• Pharmacology

Background:

• Vasomotor symptoms (VMS), including hot flashes and night sweats, are prevalent in menopausal women, affecting 80% and severely impacting quality of life for 9%.
• Treatment should focus on severely affected individuals, with personalized therapy options, as VMS often resolve within 3-5 years.
• Current recommendations favor the shortest effective duration of therapy, necessitating regular reviews.

Purpose of the Study:

• To review current literature on therapies for menopausal vasomotor symptoms.
• To evaluate treatment effectiveness, prioritizing placebo-controlled, randomized clinical trials.

Main Methods:

• Literature search conducted on PubMed.
• Keywords included 'vasomotor symptoms', 'menopause symptoms', 'hot flushes', 'hot flashes', and 'night sweats'.
• Search timeframe: 2003 to present.

Main Results:

• Estrogen therapy remains the primary treatment for VMS.
• Centrally acting medications, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and gabapentin, are increasingly utilized.
• Dietary herbal supplements, including soy and black cohosh, have demonstrated some mild efficacy, though overall benefit remains inconclusive.

Conclusions:

• Estrogen is the gold standard for managing vasomotor symptoms.
• Non-hormonal options like SSRIs, SNRIs, and gabapentin are gaining traction.
• Evidence for herbal supplements is limited, but soy and black cohosh show potential for mild symptom relief.